Analysis of buprenorphine in urine specimens.

The simultaneous determination of buprenorphine (Temgesic) and its major metabolite, N-desalkylbuprenorphine, in urine samples has been studied. By using reversed-phase high-performance liquid chromatography (HPLC) with electrochemical detection, therapeutic concentrations of unconjugated buprenorphine down to 0.2 ng/mL, and 0.15 ng/mL for the metabolite, can be detected in urine samples. This method has been applied to a variety of urine samples from drug users. The possible analytical interference from several other regulated drugs has been studied. The results were also compared with those obtained from a commercial radioimmunoassay (RIA) test. This test is only capable of detecting buprenorphine concentrations higher than 1 ng/mL.

[1]  P. Daenens,et al.  High-performance liquid chromatography with electrochemical detection of buprenorphine and its major metabolite in urine. , 1991, Journal of chromatography.

[2]  T. Kosten,et al.  Treatment of cocaine abuse with buprenorphine , 1989, Biological Psychiatry.

[3]  K. Eger.  Pharmazeutische Wirkstoffe: Ergänzungsband 1982–1987. Synthesen, Patente, Anwendungen. Von A. Kleemann und J. Engel. Georg Thieme Verlag Stuttgart 1987. XIV, 289 S., geb. DM 178,— , 1989 .

[4]  W. Bickel,et al.  A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts , 1988, Clinical pharmacology and therapeutics.

[5]  T. Kosten,et al.  Buprenorphine detoxification from opioid dependence: a pilot study. , 1988, Life sciences.

[6]  U. Bondesson,et al.  Effects of buprenorphine in heroin addicts. , 1987, Drug and alcohol dependence.

[7]  H. Derendorf,et al.  HPLC analysis of buprenorphine in plasma and urine using coulometric detection. , 1987, Journal of pharmaceutical and biomedical analysis.

[8]  J. Robertson,et al.  Drug Points: Buprenorphine: dangerous drug or overlooked therapy? , 1986 .

[9]  Rainey Hb.  Abuse of buprenorphine. , 1986 .

[10]  K. Ilett,et al.  Sensitive screening method for buprenorphine in urine. , 1986, Journal of chromatography.

[11]  J. Strang.  ABUSE OF BUPRENORPHINE , 1985, The Lancet.

[12]  E. Cone,et al.  63Ni electron-capture gas chromatographic assay for buprenorphine and metabolites in human urine and feces. , 1985, Journal of chromatography.

[13]  I. Tebbett.  Analysis of buprenorphine by high-performance liquid chromatography. , 1985, Journal of chromatography.

[14]  E. Anggard,et al.  Analysis of buprenorphine and its N-dealkylated metabolite in plasma and urine by selected-ion monitoring. , 1985, Journal of chromatography.

[15]  E. Cone,et al.  The metabolism and excretion of buprenorphine in humans. , 1984, Drug metabolism and disposition: the biological fate of chemicals.

[16]  R. Moore,et al.  Clinical Pharmacokinetics of Narcotic Agonist-Antagonist Drugs , 1983, Clinical pharmacokinetics.

[17]  R. Moore,et al.  Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis. , 1982, British journal of clinical pharmacology.

[18]  J. Mendelson,et al.  Buprenorphine suppresses heroin use by heroin addicts. , 1980, Science.

[19]  D. Jasinski,et al.  Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. , 1978, Archives of general psychiatry.

[20]  J. Thompson,et al.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.